Shigella vaccines are gaining significant attention globally due to the increasing burden of shigellosis, a contagious bacterial infection primarily caused by Shigella species. This illness, marked by severe diarrhea, poses a substantial public health challenge, particularly in low- and middle-income countries along with vulnerable pediatric populations. https://www.coherentmarketinsights.com/market-insight/shigella-vaccines-market-1110